Introduction
Colorectal cancer is the third most commonly diagnosed cancer in males and the second in females, with over 1.2 million new cancer cases and 608 700 deaths estimated to have occurred in 2008 (1) . While the rate of colorectal cancer death has been decreasing in several Western countries, it continues to increase in many countries with limited resources and health infrastructure (2) . In addition, as life expectancy continues to rise in many countries, colorectal cancer will become an even greater public health problem worldwide. Therefore, it is imperative to identify new prognostic biomarkers and therapeutic targets.
Adenomatous polyposis coli (APC) was initially identified as the gene responsible for familial adenomatous polyposis (3) (4) (5) , an autosomal, dominant inherited colorectal cancer syndrome that is characterized by early onset of numerous adenomatous colorectal polyps throughout the large intestine. If the polyps were left untreated, almost 100% of the patients with familial adenomatous polyposis would have developed colorectal cancers by the age of 40 years (6, 7) . Subsequently, APC was also found to be mutated in a majority of sporadic colorectal cancers (8) . APC Min/+ mouse (Min standing for multiple intestinal neoplasia) has a missense mutation at codon 850 of the Apc gene generated by chemical mutagenesis that introduced a chain-terminating mutation at nucleotide 2549 (9, 10) . Homozygosity for the Apc Min mutation results in embryonic lethality in the mouse, and the heterozygous mice (Apc Min/+ ) develop intestinal adenomas gradually after birth (11) . Thus, the Apc Min mouse strain has been extensively utilized as a model to investigate intestinal tumorigenesis as it has a very similar phenotype to human familial adenomatous polyposis patients.
PAQR3 is a member of the progestin and adipoQ receptor (PAQR) family and is a seven-transmembrane protein specifically located at the Golgi apparatus in mammalian cells (12, 13) . Our previous studies have revealed that PAQR3 acts as a spatial regulator of Raf kinase by sequestering Raf to the Golgi apparatus, named as RKTG (Raf kinase trapping to Golgi) (12) . PAQR3/RKTG functions as a tumor suppressor due to its inhibitory activity on Raf/MEK/ERK signaling (14) (15) (16) . When overexpressed in A375, a human malignant melanoma cell line with B-Raf mutation, PAQR3/RKTG inhibits ERK activation, cell proliferation and transformation of the cells. In addition, the tumorigenicity of the PAQR3/RKTG-expressing A375 cells is suppressed in nude mice (14) . Deletion of PAQR3/RKTG in mice leads to increased incidence of skin tumorigenesis upon induction by chemical mutagens DMBA (7,12-dimethylbenz[a] anthracene) and TPA (12-O-tetradecanoylphorbol-13-acetate) (15) . PAQR3/RKTG also has a negative effect on cell proliferation, migration, sprouting and angiogenesis of endothelial cells, and the expression level of PAQR3/ RKTG3 is significantly downregulated in clinical clear-cell renal cell carcinoma samples, with an inverse correlation with VEGF expression level (16) . Furthermore, our recent studies have indicated that PAQR3/RKTG has a functional interaction with p53 in cancer formation and epithelial-to-mesenchymal transition (17) . However, it is currently unknown whether PAQR3/RKTG also has a tumor suppressive activity in colorectal cancers.
Materials and methods

Animal studies
All animals were maintained and used in accordance with the guidelines of the Institutional Animal Care and Use Committee of the Institute for Nutritional Sciences, Chinese Academy of Sciences, with an approval number 2010-AN-8. All mice were housed at a temperature of 25°C under a 12-h dark/light cycle. C57BL/6J mice were obtained from Shanghai Laboratory Animal Co., Ltd. (SLAC, Shanghai, China). Paqr3-null mice (12, 15) in C57BL/6J background were generated by crossing with C57BL/6J mice for at least five generations. The C57BL/6J-APC Min /J strain was obtained from Model Animal Research Center of Nanjing University, Nanjing, Jiangshu, China, and the genotyping was performed by the protocol database described in the website of The Jackson Laboratory (Bar Harbor, Maine, USA). The mice were fed with normal chow, and both male and female were used for the experiments in this study.
Histological analysis
The small intestine and colon were excised promptly after euthanasia and placed in 10% formalin/phosphate-buffered saline, fixed overnight and then embedded in paraffin. Paraffin sections were used for hematoxylin and eosin staining and immunohistochemistry. For Ki67 immunostaining, the paraffin-embedded sections were de-paraffinized in xylenes and rehydrated in graded alcohols and then in PBS for 5 min. Antigen retrieval was performed by boiling for 15 min in 10 mM sodium citrate buffer (pH 6.0), followed by cooling to room temperature. The sections were then incubated in blocking buffer (5% goat serum in PBS) for 1 h at room temperature, followed by incubation with a monoclonal anti-Ki67 antibody for overnight at 4°C. The sections were rinsed three times in PBS and incubated for 1 h at room temperature in secondary antibody (donkey anti-mouse IgG Alexa fluor 488) and the nuclei were stained by Hoechst 33342. The TdT-mediated dUTP-biotin nick end labeling (TUNEL) assay was performed following the manufacturer's instruction (Chemicon, Temecula, CA).
cells were purchased from and tested by the Bank/Stem Cell Bank, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences (Shanghai, China), and were maintained in Leibovitz's L-15 Medium supplemented with 10% FBS and 1% penicillin/streptomycin. Lentivirus was generated by co-transfection in HEK293T cells as previously described (14) (15) (16) .
MTT assay
The MTT (Thiazolyl Blue Tetrazolium Bromide, from Sigma-Aldrich, St. Louis, MO, USA) assay was performed according to the method described by Mosmann (18) . SW-480 cells were seeded (5 × 10 3 cells/well) in a 96-well culture plate and incubated for different length of time. At the time of experiment, the culture medium was discarded and the plate was incubated at 37°C for 4 h with MTT (5 mg/ml). The MTT solution was then discarded, and dimethyl sulfoxide was added to dissolve the formazan product. The optical density was measured at 550 nm using a Uniscience spectrophotometer plate reader.
Soft agar assay SW-480 cells were plated (1 × 10 4 cells/well) into a 6-well plate by using a 2-layer soft agar system using a protocol as previously described (19) . After incubation at 37°C for 10 days, the colonies were photographed and counted in three random fields under OLYMPUS inverted microscope CKX41.
Antibodies and immunoblotting
The antibodies were purchased as follows: The antibodies against Myc and total ERK1/2 were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The antibodies against phospho-ERK1/2 were from Cell Signaling Technology (Danvers, MA, USA). The antibodies against TBP were from Abcam (Cambridge, MA, USA). The antibodies against β-catenin were from BD Biosciences Transduction Laboratories (Lexington, KY, USA). Alexa fluor 488 donkey anti-mouse IgG and Hoechst 33342 were from Molecular Probes (Eugene, OR, USA). The anti-Ki67 antibody was from BD Biosciences Pharmingen (San Diego, CA). ApopTag ® Peroxidase in Situ Apoptosis Detection Kit was from Chemicon (Temecula, CA). The protocol for immunoblotting has been described previously (12) .
Human colorectal cancer samples
Sixty-two pairs of primary colorectal cancer and their corresponding adjacent normal tissues were obtained from colorectal cancer patients treated at Zhongshan Hospital (Shanghai, China) after their written informed consent. The fresh samples were snap-frozen in liquid nitrogen and stored at −80°C until analysis.
Real-time polymerase chain reaction
Real-time quantitative polymerase chain reaction (RT-PCR) was conducted with ABI Prism 7900 sequence detection system following the manufacturer's recommendations (Applied Biosystems, Foster City, CA, USA). The primers are as follows: 5'-GATGGCATTGGATTATGCAG-3' and 5'-AAGCACGG TGATCAGGTACA-3' for PAQR3, 5'-GATCATTGCTCCTCCTGAGC-3' and 5'-ACTCCTGCTTGCTGATCCAC-3' for actin.
Statistical analysis
Student's test was used for the experiments except for analysis of human cancer samples. χ2 or Fisher's exact test (SAS 9.2 statistical software) was used to analyze the data of human colorectal samples.
Results
Deletion of Paqr3 reduces the survival time and enhances tumor number and area in Apc
Min/+ mice To explore the potential impact of PAQR3 on the formation of intestine tumors, we crossed Paqr3-deleted mice with Apc Min/+ mice. The average survival was 31 weeks for Apc Figure 3C ).
PAQR3 regulates cell growth and colony formation in SW-480 colon cancer cells
To provide additional evidence that PAQR3 is implicated in the development of colon cancers, we analyzed SW-480 colon cancer cell line that harbors mutated APC and oncogenic KRAS (20) . To investigate whether PAQR3 plays a role in the growth and colony formation capability in SW-480 cells, we employed lentivirusmediated overexpression and shRNA to either upregulate or downregulate the expression of PAQR3. The effect of PAQR3 on cell proliferation rate was evaluated by MTT and growth-curve assays ( Figure 4A-D) . Previously, we identified a PAQR3 shRNA (#3-121) that had a high efficiency to knock down endogenous PAQR3 in HUVECs (16) . As expected, this PAQR3 shRNA (#3-121) could markedly reduce the expression of endogenous PAQR3 in SW-480 cells ( Figure 4B, inset) . Interestingly, overexpression of PAQR3 in SW-480 cells significantly inhibited cell proliferation rate ( Figure 4A and 4C). In contrast, the cell proliferation rate was strongly enhanced by PAQR3 knockdown ( Figure 4B and 4D) . Moreover, the number of colonies formed in soft agar was significantly decreased by PAQR3 overexpression and markedly elevated by PAQR3 downregulation ( Figure 4E ). Taken together, these results indicate that the cell proliferation rate and anchorage-independent growth of SW-480 cells were affected by the expression level of PAQR3.
PAQR3 regulates EGF-induced ERK phosphorylation and nuclear accumulation of β-catenin in SW-480 colon cancer cells
Our previous studies indicate that PAQR3 is a spatial regulator of Raf kinase and plays a critical role in the regulation of the Ras/Raf/ MEK/ERK signaling cascade (12, 14, 16) . Furthermore, PAQR3 has been found to be implicated in epithelial-to-mesenchymal transition partly through regulation on β-catenin (17). We therefore analyzed the effect of PAQR3 on EGF-induced ERK phosphorylation and nuclear accumulation of β-catenin in SW-480 cells. As expected, treatment of SW-480 cells with EGF could stimulate ERK phosphorylation
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( Figure 5A ). Overexpression of PAQR3 significantly abrogated EGF-induced ERK phosphorylation ( Figure 5A ). In contrast, when the endogenous PAQR3 was silenced by a specific shRNA, the EGF-stimulated ERK phosphorylation was markedly enhanced ( Figure 5A ). Furthermore, the enhanced ERK phosphorylation by PAQR3 knockdown could be completely blocked by a MEK inhibitor, U0126 ( Figure 5A ). In addition, the cell proliferation rate of SW-480 cells was also strongly decreased by treatment with U0126 ( Figure 5B) . Intriguingly, the enhanced cell proliferation rate by PAQR3 knockdown could be completely abrogated by U0126 ( Figure 5B ). These data, collectively, further support our findings that PAQR3 regulates cell functions through modulating Raf/MEK/ERK signaling pathway.
In addition, EGF could stimulate nuclear accumulation of β-catenin in SW-480 cells ( Figure 5C ). Interestingly, both the basal and EGF-stimulated nuclear accumulation of β-catenin was diminished by PAQR3 overexpression and elevated by PAQR3 downregulation ( Figure 5C ). These data, therefore, indicate that PAQR3-mediated regulation on ERK phosphorylation and nuclear accumulation of β-catenin may underlie the growth inhibitory effect of PAQR3 in colon cancer cells.
PAQR3 is downregulated in human colorectal cancer samples
We next explored whether the expression level of PAQR3 in human colorectal cancer was altered. The mRNA level of PAQR3 was quantified by RT-PCR in 62 pairs of human colorectal tumors and their matched normal tissues (Figure 6 ). Decreased expression of PAQR3 occurred in 51 of 62 (82.3%) colorectal tumors compared with the paired normal colorectal tissues (Figure 6 ). Univariate analysis revealed that the mRNA expression level of PAQR3 was significantly decreased in the cancer samples in comparison with adjacent normal tissues (p < 0.001).
To further investigate the role of PAQR3 in colorectal cancers, we analyzed the correlation between PAQR3 mRNA levels and clinical and 
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pathologic characteristics. PAQR3 was more likely to be downregulated in male patients than the females (87.2% in male and 66.7% in female, p = 0.0385) (Table I ). Furthermore, the mRNA level of PAQR3 in male patients was inversely associated with tumor grade (p = 0.0333) (Table II) . These results, therefore, highly suggest that PAQR3 is likely implicated in the development of colorectal cancers in humans.
Discussion
In this study, we provided three major pieces of evidence that implicates PAQR3 in the tumorigenesis of colorectal cancers. At the cellular level, PAQR3 was able to regulate cell proliferation rate, anchorage-independent growth, ERK phosphorylation and nuclear accumulation of β-catenin in SW-480 colon cancer cells. At the animal level, Paqr3 deletion could enhance tumorigenesis in Apc Min/+ mice. In humans, the expression level of PAQR3 was significantly downregulated in colorectal cancer samples in comparison with their matched normal tissues. In addition, a reduced PAQR3 expression in the colon cancer samples was associated with an increase in tumor grade. Collectively, these data suggest that PAQR3 plays tumor suppressor role in the development of colorectal cancers. 
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The findings that APC is implicated in colorectal cancer development has pinpointed the importance of Wnt signaling, which is involved in virtually every cellular function, including cell growth, proliferation, polarity, differentiation and development (21, 22) . Dysregulation of Wnt signaling pathway has been implicated in the formation of colorectal cancers (23, 24) . Wnt signaling is strictly regulated in normal cells. In the absence of Wnt protein, cytoplasmic β-catenin is maintained at a low abundance by a destruction complex that contains several proteins, including axin, APC, casein kinase I and glycogen synthase kinase 3 (21) . In cells harboring mutated APC, β-catenin accumulates and, following its translocation into the nucleus, is able to interact with TCF-LEF transcription factors (25, 26) . The β-catenin/TCF-LEF complex then initiates transcriptional regulation on a large array of genes including those regulating cell proliferation and cell cycle, such as c-myc and cyclin D1 (27, 28) , consequently leading to elevated cell proliferation in cells.
However, recent studies have revealed that the cellular changes mediated by APC loss are not sufficient to confer tumor progression and that Ras-mediated signaling is indispensible for full blown colorectal cancer development. About 40-50% of human colorectal cancers bear KRAS mutations (29) . Deletion of MyD88, a downstream mediator of Toll-like receptors, reduces multiple intestinal neoplasia (Min) Fig. 5 . PAQR3 regulates EGF-induced ERK phosphorylation and nuclear accumulation of β-catenin in SW-480 cells. SW-480 cells were infected with control, PAQR3-expression or PAQR3 shRNA lentivirus. After serum-starvation overnight, SW-480 cells were treated with or without 100 ng/ml of EGF for 30min. Whole cell lysate (A) and the nuclear fraction (C) were used in immunoblotting with the antibodies as indicated. A MEK-specific inhibitor U0126 (5 µM for 6 h) was used as indicated for A. In addition, SW-480 cells infected with either the control or PAQR3 shRNA lentivirus were treated with or without U0126 (5 µM) for 48 h before the analysis of cell numbers (B). The data are shown as mean ± SD. ** indicates p < 0.01 between the groups infected with control and PAQR3 shRNA lentivirus. ^^ indicates p < 0.01 between U0126-treated and untreated cells infected with the same virus at 48 h after the treatment.
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phenotypes in APC Min/+ mice. Such amelioration of Min phenotype is abrogated by EGF-mediated activation of ERK and aggravated by ERK inhibitor (30) , indicating that ERK-mediated signaling is required for tumorigenesis upon APC deficiency. Interestingly, loss of APC is not sufficient to initiate nuclear translocation of β-catenin (20, 31, 32) . It was found that KRAS activation is required to achieve maximal nuclear accumulation of β-catenin and tumor progression in APC-deficient mice (20) , indicating that Ras-mediated signaling is indispensible for tumor progression upon APC loss. As one of the major functions of PAQR3 is negative regulation of Ras/Raf/MEK/ERK signaling cascade (12), our results would further corroborate the importance of Ras-mediated signaling in the tumorigenesis of colorectal cancers. Consistently, our study found that nuclear accumulation of β-catenin is increased by PAQR3 downregulation and reduced by PAQR3 overexpression ( Figure 5C ), further indicating the importance of Ras/Raf/MEK/ERK signaling in APC loss-mediated development of colorectal cancers. Bearing these findings in mind, it will be important to elucidate in the future the mechanism underlying PAQR3 regulation on APCand β-catenin-mediated cellular changes as well as the functional implication in the development of colorectal cancers. Furthermore, it will be important to investigate whether our findings about PAQR3 downregulation in human colorectal cancers can aid in the identification of a new tumor marker and a new therapeutical target. 
